Zinbryta (daclizumab) is a medication used to treat adults with relapsing forms of multiple sclerosis (MS). Multiple sclerosis is a neurological disease that scars nerve tissue and causes a range of symptoms, including pain, vision loss, impaired coordination and paralysis. MS affects more than 2.3 million people worldwide.

Zinbryta is not a cure for MS, but helps prevent the immune system from attacking the nerves in the brain and spinal cord. Doctors generally prescribe Zinbryta to patients who have tried two or more other MS medications and not experienced positive results. It is injected under the skin, typically once a…
Continue Reading Zinbryta Lawsuit Attorneys